Drug Shortage Report for FLUDARA

Last updated on 2023-04-13 History
Report ID 167783
Drug Identification Number 02246226
Brand name FLUDARA
Common or Proper name Fludarabine phosphate
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) FLUDARABINE PHOSPHATE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 4 Blister packs
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-09-01
Actual start date 2022-09-01
Estimated end date 2023-03-31
Actual end date 2023-03-31
Shortage status Resolved
Updated date 2023-04-13
Company comments Allocation has been initiated and may continue through March 2023.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-04-13 English Compare
v11 2023-04-01 English Compare
v10 2023-03-31 French Compare
v9 2023-03-31 English Compare
v8 2022-11-02 French Compare
v7 2022-11-02 English Compare
v6 2022-09-15 English Compare
v5 2022-09-07 French Compare
v4 2022-09-07 English Compare
v3 2022-09-02 English Compare
v2 2022-08-25 French Compare
v1 2022-08-25 English Compare

Showing 1 to 12 of 12